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Vascular Cell has launched a new series on macrophages and angiogenesis, a quickly evolving field critical to blood
and lymphatic vessels during development, inflammation and tumorigenesis.Editorial
The term “macrophage” comes from the Greek for “large
eaters”, a name that reflects the prominent phagocytic
activity. Arising from the embryo, yolk sac, or the bone
marrow, macrophages are most widely appreciated as
critical members of the inflammatory response to patho-
gens; however, their close physical association with
blood vessels has earned them increased attention from
angiogenic researchers. Recent studies have established
that macrophages influence blood vessel development
during growth, tissue repair, and tumorigenesis, and
their widespread contributions to angiogenesis are only
beginning to be understood.
Vascular Cell presents a new thematic series entitled
“Macrophages and Angiogenesis”, that provides reviews
and analyses from experts in this emerging field. The
functions of macrophages are as numerous as the names
given to these myeloid-derived cells, and while the gen-
eral focus here is on macrophages, the individual reviews
range far and wide in their consideration of myeloid-
derived cells involved in angiogenesis. The three initial
articles of the series review the potential angiogenic ac-
tivities of inflammatory macrophages, resident macro-
phages, microglia, retinal myeloid cells, dendritic cells,
myeloid-derived suppressor cells, and more. A range of
blood vessel types are considered, with discussion of de-
velopmental vessels, adult tissue vessels, tumor vessels
and lymphatic vessels.* Correspondence: jkk9@columbia.edu
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reproduction in any medium, provided the orNatasha Harvey and Emma Gordon consider the
interface between macrophages and lymphangiogenesis
in their review entitled, “Deciphering the roles of
macrophages in developmental and inflammation sti-
mulated lymphangiogenesis” [1]. The authors consider
the developmental origins of macrophages in relation
to the development of the lymphatic vascular system,
and discuss the intimate relationship between macro-
phages and lymphatic endothelial cells. They provide
an excellent description of how macrophages guide
and grow the lymphatic vasculature, and the mechan-
isms involved in this interaction. Both lymphatics and
macrophages are key to the inflammatory response,
and the authors describe the ways in which they work
together to mediate both host responses during inflam-
mation and lymphatic vessel growth. They extend their
analysis to a discussion of tumor lymphangiogenesis,
which highlights the key roles for macrophages during
this pathological process. In closing, the authors
synthesize an elegant model to highlight and consider
the diverse roles of macrophages in developmental, in-
flammatory, and tumor lymphangiogenesis.
The article by Andrew Newman and Christopher
Hughes, entitled, “Macrophages and angiogenesis: a
role for Wnt signaling” [2], explores the roles for Wnt
signaling molecules in macrophage biology, with a
focus on angiogenic regulation. Wnts are key morpho-
gens and mitogens, and among their diverse functions
are the abilities to both promote blood vessel growth
and to drive their regression. A thorough introduction
to Wnt function in angiogenesis is followed by an out-
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ities highlights Wnt-5a, which regulates angiogenesis by
both direct and indirect mechanisms. They next discuss
Wnt signaling effector proteins that mediate the angio-
genic response to macrophages, including matrix
metallo-proteinases (MMPs) and the endothelial receptor
tyrosine kinase, Tie-2. The authors highlight recent ele-
gant studies of macrophages in the eye, where they are
critical for both regressing hyaloid vessels and for pat-
terning retinal vasculature. The article closes with a
model that considers how Wnts integrate these diverse
angiogenic activities, with special attention paid to
chemotactic cytokines released by macrophages.
The tumor microenvironment is full of myeloid-
derived cells, and this is the topic covered by Michael
Schmid and Judith Varner in their contribution entitled,
“Myeloid cells in tumor inflammation” [3]. The concept
of a tumor as a “wound that never heals”, posited by
Harold Dvorak [4], highlights the intense inflammatory
response that arises during tumorigenesis. Schmid and
Varner describe the myeloid lineage cells involved in
tumor inflammation and angiogenesis, and provide a
guide to the surface markers that distinguish the key cell
types. They pay special attention to myeloid-derived
suppressor cells, which are the immunosuppressive cells
that inhibit innate and adaptive immunity to promote
tumor immune escape. Tumor cells secrete a diverse
array of cytokines, and the authors discuss the cytokines
that are involved in recruitment of tumor-associated
macrophages. They additionally describe the mechan-
isms by which integrins function to recruit myeloid cells
to the tumor microenvironment, and review the studies
that have demonstrated this link. How macrophages may
promote tumor angiogenesis and metastasis is a key
element of this comprehensive analysis, and of particular
interest is a discussion of how myeloid cells function in
relapse or resistance to anti-tumor therapies. These
authors synthesize several complex processes, involving
diversity of myeloid cells and the tumor environment,
into a series of well-crafted descriptions of the players,
the processes, and implications for therapy.
More contributions are on their way, and we encourage
experts in the field to contribute their analyses to this
series. To submit your manuscript, please use the online
submission system for Vascular Cell and indicate in your
cover letter that you would like it to be considered for
this thematic series. Or, please send a pre-submission en-
quiry to jkk9@columbia.edu and join this venue to teach
and learn about macrophages in angiogenesis.
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